AI 聊天
Loading data for BFRI — first visit, this takes a few seconds.

Biofrontera Inc.

BFRI · NasdaqCM · USD

1.55 +0.09 (6.16%)

收盤價: Sep 14, 2026, 1:56 PM

市值
$21.68M
下次財報日期
Nov 11, 2026

Biofrontera Inc.(BFRI)股價、分析與資料

內在價值

正在載入內在價值…

分析師預測

股票預測 →

分析師預測無法取得

12個月目標價 · n/a 位分析師

分析師共識: n/a

間隔:1D
正在載入K線和訊號…

財務表現

查看財務 →
營收 (ttm)
$46.17M

正在載入...

最新財報

已通報較預期YoY 變更
營收$12.00Mn/a+32.92%
EPS-$0.05-$0.01+91.23%

下次財報

開盤前。

估計 · 升級 →

查看財報詳情 →

指標

買價
1.14
市值
21.7M
淨利(ttm)
-6.37M
0.84
-0.43
n/a
3.4
P/B (ttm)
3.48
P/S (ttm)
0.47
財報日期
Nov 11, 2026
賣價
1.98
成交量
1,398,400
20 日平均成交量
507,588
開盤價
1.54
前收盤價
1.46
當日區間
1.50 - 1.62
52 週範圍
0.56 - 1.66
股利
n/a
除息日
n/a

關於 Biofrontera Inc.

查看公司資料 →
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts. Drug Manufacturers - Specialty & Generic · Healthcare

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

類股 Healthcare
IPO 日期 Oct 29, 2021
員工 84
證券交易所 NasdaqCM
股票代號 BFRI